Full Text View
Tabular View
No Study Results Posted
Related Studies
Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair
This study is currently recruiting participants.
Verified by University of Southern California, August 2007
First Received: August 22, 2007   No Changes Posted
Sponsored by: University of Southern California
Information provided by: University of Southern California
ClinicalTrials.gov Identifier: NCT00520416
  Purpose

Endovascular repair of infrarenal abdominal aortic aneurysms (AAA) requires a contrast agent to identify the vascular anatomy and placement of the stent graft. Iodine contrast has traditionally been used, but has the potential to harm the kidneys. Another contrast agent is carbon dioxide gas. It has been proven safe to use, but the quality of the images it creates needs to be compared to iodine contrast. Patients in this study undergo the endovascular AAA repair as they normally, with the iodine contrast. At the end of surgery carbon dioxide gas contrast is given as an extra step. The images will be later evaluated.


Condition Intervention
Carbon Dioxide
Endovascular Abdominal Aortic Aneurym Repair
Prospective
Angiogram
Procedure: Carbon dioxide angiogram

MedlinePlus related topics: Aneurysms Gas
Drug Information available for: Carbon dioxide
U.S. FDA Resources
Study Type: Observational
Study Design: Screening, Longitudinal, Defined Population, Prospective Study

Further study details as provided by University of Southern California:

Study Start Date: October 2006
Estimated Study Completion Date: August 2008
Groups/Cohorts Assigned Interventions
1: Case
There is no control or experimental group. The same patients undergoing endovascular AAA repair with serve as their own control
Procedure: Carbon dioxide angiogram
see description of procedure

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Infrarenal abdominal aortic aneurysm amendable to endovascular repair

Exclusion Criteria:

  • renal failure or contraindication to receiving iodine contrast.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00520416

Contacts
Contact: Wesley Lew, MD 323-442-5988 wlew@surgery.usc.edu

Locations
United States, California
USC University Hospital Recruiting
Los Angeles, California, United States, 90033
Sponsors and Collaborators
University of Southern California
Investigators
Principal Investigator: Fred A Weaver, MD University of Southern California
  More Information

No publications provided

Study ID Numbers: HS-06-00263
Study First Received: August 22, 2007
Last Updated: August 22, 2007
ClinicalTrials.gov Identifier: NCT00520416     History of Changes
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Aneurysm
Flatulence

ClinicalTrials.gov processed this record on May 07, 2009